Seizert Capital Partners’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-19,416
Closed -$326K 180
2025
Q2
$326K Sell
19,416
-476
-2% -$6.43K 0.01% 145
2025
Q1
$255K Hold
19,892
0.01% 146
2024
Q4
$351K Buy
19,892
+2,224
+13% +$42.2K 0.02% 137
2024
Q3
$404K Buy
17,668
+6,190
+54% +$140K 0.02% 134
2024
Q2
$263K Buy
11,478
+3,328
+41% +$103K 0.01% 147
2024
Q1
$323K Hold
8,150
0.01% 144
2023
Q4
$322K Sell
8,150
-2,275
-22% -$95.2K 0.02% 146
2023
Q3
$463K Sell
10,425
-1,278
-11% -$55.8K 0.02% 129
2023
Q2
$509K Sell
11,703
-809
-6% -$35.6K 0.03% 129
2023
Q1
$544K Sell
12,512
-2,946
-19% -$130K 0.03% 134
2022
Q4
$577K Hold
15,458
0.03% 149
2022
Q3
$615K Sell
15,458
-486
-3% -$18K 0.03% 135
2022
Q2
$610K Hold
15,944
0.03% 158
2022
Q1
$632K Hold
15,944
0.03% 159
2021
Q4
$662K Buy
15,944
+8,453
+113% +$367K 0.03% 160
2021
Q3
$316K Buy
+7,491
New +$377K 0.01% 184

Other funds holding NRC

Seizert Capital Partners's NRC Position: Q3 2025 in Review

Seizert Capital Partners sold out of NRC Health Common Stock (NRC) in Q3 2025, closing a stake of 19,416 shares — an estimated $326K sold.

Seizert Capital Partners first reported a position in NRC in Q3 2021 and held it in 16 quarters. The position peaked at $662K in Q4 2021. 118 funds tracked by Wall St. Rank hold NRC as of Q3 2025.

  • Seizert Capital Partners reported no remaining NRC Health Common Stock position as of Q3 2025 after selling out during the quarter.
  • Seizert Capital Partners sold 19,416 NRC Health Common Stock shares in Q3 2025, an estimated $326K.
  • Seizert Capital Partners first reported a position in NRC Health Common Stock in Q3 2021 and held it in 16 quarters.
  • Seizert Capital Partners's NRC Health Common Stock position peaked at $662K in Q4 2021.
  • 118 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q3 2025.

Based on Seizert Capital Partners's 13F filing for Q3 2025, filed 29 Oct 2025.